Time to Benefit-Reference-Cited by-同舟云学术

Time to Benefit

Published:2005-03 Issue:1 Volume:4 Page:43-45
ISSN:1535-282X
Container-title:Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine
language:en
Short-container-title:

Author:

Ray Kausik K.,Cannon Christopher P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).;Lancet,1994

2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.;Sacks;N Engl J Med,1996

3. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS).;Circulation,1998

4. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.;Shepherd;N Engl J Med,1995

5. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.;Downs;JAMA,1998

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efferocytosis in atherosclerosis;Nature Reviews Cardiology;2024-05-15

2. Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years;JAMA Internal Medicine;2021-02-01

3. The Effect of Statins on the Functionality of CD4+CD25+FOXP3+ Regulatory T-cells in Acute Coronary Syndrome: A Systematic Review and Meta-analysis of Randomised Controlled Trials in Asian Populations;European Cardiology Review;2019-07-11

4. UNDERSTANDING AND ANTICIPATING LAG-TIME BIAS IN COST-EFFECTIVENESS STUDIES: THE ROLE OF TIME IN COST-EFFECTIVENESS ANALYSIS;International Journal of Technology Assessment in Health Care;2014-12

5. Rationalizing Prescribing for Older Patients with Multimorbidity: Considering Time to Benefit;Drugs & Aging;2013-06-08